Strata Critical Medical, Inc. Cash Flow Reinvestment Rate
Latest as of March 2026:
10.12x
Strata Critical Medical, Inc. cash flow reinvestment rate. Strata Critical Medical, Inc. (SRTA) has a Cash Flow Reinvestment Rate of 10.12x as of March 2026, reinvesting $35.98 Million (capex $5.48 Million plus investments $30.50 Million) from operating cash flow of $3.56 Million. Explore SRTA operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
10.12x
(Capex + Investments) / Operating CF
Total Reinvested
$35.98 Million
Capex + Investments
Operating Cash Flow
$3.56 Million
USD
Capital Expenditures
$5.48 Million
USD
Strata Critical Medical, Inc. Cash Flow Reinvestment Rate by Year (None–None)
Strata Critical Medical, Inc. cash flow reinvestment rate by year from None to None. Year-by-year capital reinvestment analysis for Strata Critical Medical, Inc.. For the full cash flow conversion analysis, see SRTA operating cash flow.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow